#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11794	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2125	548.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	687	C,T	658,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11794	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2125	548.7	0	HET	.	.	.	C207T	.	207	207	C	442	442	C	654	C,T	472,142	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3573	620.3	0	.	n	.	0	T695C	SNP	695	695	T	1110	1110	C	697	C,T	668,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3573	620.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2386	2386	C	666	C	633	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3573	620.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2460	2460	A	639	A	625	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3573	620.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3012	3012	C	654	C	628	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	12	blaTEM	861	469	99.79	blaTEM.l6.c30.ctg.1	469	1.7	0	.	p	.	0	A16V	NONSYN	46	48	GCA	38	40	GTA	1;1;1	G;T;A	1;1;1	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1458	folP	855	855	100.0	folP.l6.c4.ctg.1	1363	105.1	1	SNP	p	R229S	1	.	.	685	687	AGC	938	940	AGC	129;130;129	A;G;C	124;127;122	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4414	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3388	129.1	1	SNP	p	S91F	1	.	.	271	273	TTC	647	649	TTC	152;154;150	T;T;C	147;147;143	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4414	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3388	129.1	1	SNP	p	G95N	0	.	.	283	285	GGC	659	661	GGC	148;147;148	G;G;C	142;140;139	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4414	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3388	129.1	1	SNP	p	D95G	1	.	.	283	285	GGC	659	661	GGC	148;147;148	G;G;C	142;140;139	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1460	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1278	112.8	1	SNP	p	G45D	0	.	.	133	135	GGC	428	430	GGC	191;188;189	G;G;C	182;182;182	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	736	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1207	60.8	0	.	n	.	0	A197.	DEL	197	197	A	650	650	A	174	A	170	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3718	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2896	127.0	1	SNP	p	D86N	0	.	.	256	258	GAC	548	550	GAC	155;155;158	G;A;C	146;142;147	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3718	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2896	127.0	1	SNP	p	R87I	0	.	.	259	261	CGT	551	553	CGT	157;155;155	C,A;G;T	146,1;147;146	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3718	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2896	127.0	1	SNP	p	R87W	0	.	.	259	261	CGT	551	553	CGT	157;155;155	C,A;G;T	146,1;147;146	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3718	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2896	127.0	1	SNP	p	S87R	1	.	.	259	261	CGT	551	553	CGT	157;155;155	C,A;G;T	146,1;147;146	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3718	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2896	127.0	1	SNP	p	S88P	0	.	.	262	264	TCC	554	556	TCC	156;157;155	T;C;C	149;150;147	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3280	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2777	116.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1550	1552	GGC	180;177;174	G;G;C	170;168;163	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1137	1139	GCC	191;188;188	G;C;C	185;183;182	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1140	1142	ATG	190;187;185	A;T;G	183;176;177	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1152	1154	ACC	188;188;187	A;C;C	177;183;181	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1152	1154	ACC	188;188;187	A;C;C	177;183;181	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1653	1655	ACC	181;180;183	A;C;C	165;168;170	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1707	1709	GCG	188;185;186	G;C;G	179;179;178	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1707	1709	GCG	188;185;186	G;C;G	179;179;178	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1830	1832	GGT	130;131;130	G;G;T	126;127;124	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1839	1841	AGC	126;125;122	A;G;C	122;121;119	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3368	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2231	148.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1857	1859	CCG	100;101;98	C,G;C,G;G,T,C	90,2;90,2;80,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4776	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3099	152.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1634	1636	CCG	162;164;162	C,G;C;G	149,1;156;151	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1936	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1821	105.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	127	C,G	118,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2070	porB1b	1038	1038	99.04	porB1b.l6.c17.ctg.1	1664	122.9	0	.	p	.	0	E209_G210del	DEL	625	625	G	920	920	G	158	G,A	145,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2070	porB1b	1038	1038	99.04	porB1b.l6.c17.ctg.1	1664	122.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	936	938	GGT	157;160;158	G;G;T	151;156;153	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2070	porB1b	1038	1038	99.04	porB1b.l6.c17.ctg.1	1664	122.9	1	SNP	p	G120K	1	.	.	358	360	AAG	654	656	AAG	148;149;153	A;A;G	145;147;143	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2070	porB1b	1038	1038	99.04	porB1b.l6.c17.ctg.1	1664	122.9	1	SNP	p	A121N	1	.	.	361	363	AAC	657	659	AAC	153;155;159	A;A;C	148;149;152	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2070	porB1b	1038	1038	99.04	porB1b.l6.c17.ctg.1	1664	122.9	1	SNP	p	N121D	0	.	.	361	363	AAC	657	659	AAC	153;155;159	A;A;C	148;149;152	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7664	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4978	152.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	862	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1043	82.0	1	SNP	p	V57M	1	.	.	169	171	ATG	512	514	ATG	170;172;171	A;T;G	160;161;161	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
